MAM
Zee TV climbs back to No 2 on the back of DID finale
MUMBAI: Zee TV has climbed back to number two spot on the back of the grand finale of the third season of its popular dance reality show Dance India Dance.
As per TAM data for week ended 21 April (HSM, C&S, 4+), the finale of DID 3 aired on 21 Apri garnered a 3.19 TVR helping the channel to pocket 214 GRPs (gross rating points). The channel had clocked 192 GRPs in the previous week.
Zee TV‘s gain happened in a week when the Hindi GEC genre continued its downslide due to the Indian Premier League, shedding 10 GRPs after losing 51 points in the trailing week.
Star Plus maintained its leadership position, albeit losing 13 GRPs. It endedThe channel ended the week with 248 GRPs as its top-rated shows saw marginal loss in their ratings.
Taking the No. 3 and 4 spots respectively, Sony Entertainment Television (Set) and Colors added four GRPs each to their last week’s tally. Set ended the week with 209 GRPs, while Colors had to rest satisfied with 194 GRPs in its kitty.
Sab, meanwhile, lost seven GRPs to close the week with 115 GRPs while Star‘s second GEC, Life OK, managed to add one GRP to close with 86 GRPs.
Sahara One ended 45 GRPs (last week 46). Imagine TV, the channel which ceased operations and has been running repeat content, closed the week with 41 GRPs, down from 57 GRPs last week.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
